![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 1
2022
Casulo, Carla 
ORCID: https://orcid.org/0000-0003-4998-9932; Dixon, Jesse G.; Le-Rademacher, Jennifer ORCID: https://orcid.org/0000-0002-2234-7430; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hochster, Howard S. ORCID: https://orcid.org/0000-0002-9893-1529; Hiddemann, Wolfgang; Marcus, Robert; Kimby, Eva; Herold, Michael; Sebban, Catherine; Gyan, Emmanuel ORCID: https://orcid.org/0000-0002-7651-9189; Foon, Kenneth; Nielsen, Tina; Vitolo, Umberto ORCID: https://orcid.org/0000-0001-7772-2747; Salles, Gilles A. ORCID: https://orcid.org/0000-0002-9541-8666; Shi, Qian und Flowers, Christopher R.
(2022):
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
In: Blood, Bd. 139, Nr. 11: S. 1684-1693
ORCID: https://orcid.org/0000-0003-4998-9932; Dixon, Jesse G.; Le-Rademacher, Jennifer ORCID: https://orcid.org/0000-0002-2234-7430; Hoster, Eva ORCID: https://orcid.org/0000-0002-0749-1389; Hochster, Howard S. ORCID: https://orcid.org/0000-0002-9893-1529; Hiddemann, Wolfgang; Marcus, Robert; Kimby, Eva; Herold, Michael; Sebban, Catherine; Gyan, Emmanuel ORCID: https://orcid.org/0000-0002-7651-9189; Foon, Kenneth; Nielsen, Tina; Vitolo, Umberto ORCID: https://orcid.org/0000-0001-7772-2747; Salles, Gilles A. ORCID: https://orcid.org/0000-0002-9541-8666; Shi, Qian und Flowers, Christopher R.
(2022):
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials.
In: Blood, Bd. 139, Nr. 11: S. 1684-1693